Nuvectis Pharma (NVCT)'s 30-day implied volatility (IV30) was 51.0% at the close on November 18, 2026, down from 66.7% the day before, against a 52-week range of 39.4% to 185.7%. Its 20-day historical volatility was 84.5%.
Data as of November 18, 2026.